Contineum Therapeutics, Inc. Class A Common Stock
HealthcareNASDAQ:CTNM · NASDAQ Global Select
+$0.02 today
Vol 0.11M · Avg 0.26M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+168.17%
Period High
$16.00
Period Low
$3.65
Latest
$11.88
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Capricor Therapeutics, Inc.
NASDAQ:CAPR
$1.18B
Alto Neuroscience, Inc.
NYSE:ANRO
$753.47M
Candel Therapeutics, Inc.
NASDAQ:CADL
$469.95M
Kyverna Therapeutics, Inc.
NASDAQ:KYTX
$352.74M
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO
$343.14M
Silence Therapeutics plc
NASDAQ:SLN
$316.00M
Amarin Corporation plc
NASDAQ:AMRN
$315.21M
AC Immune S.A.
NASDAQ:ACIU
$235.10M
Aldeyra Therapeutics, Inc.
NASDAQ:ALDX
$106.17M
Mereo BioPharma Group plc
MREO
$48.68M
What is the latest CTNM filing?
The latest filing shown is 4 dated Jun 1, 2026.
How many recent filings does CTNM have?
Intrinsic Alpha currently shows 20 recent filings for CTNM.
Explore More
Continue the stock analysis
Jump to another research area for this company.